{
  "paper_metadata": {
    "pmid": "34432383",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 43,
        "demographics": "Mean age 74 years, majority male",
        "phenotype": "Transthyretin amyloid cardiomyopathy (ATTR-CM)"
      },
      "penetrance_data": {
        "total_carriers_observed": 43,
        "affected_count": 27,
        "unaffected_count": 16,
        "uncertain_count": null,
        "penetrance_percentage": 62.8,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Severe disease presentation",
          "evidence_sentence": "Overall, all-cause mortality was greatest in patients with ATTRv who were NYHA Class III at baseline (78.9%), followed by patients with ATTRwt who were NYHA Class III (54.5%)..."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms reported",
          "evidence_sentence": "Overall, all-cause mortality was greatest in patients with ATTRv who were NYHA Class III at baseline (78.9%), followed by patients with ATTRwt who were NYHA Class III (54.5%)..."
        }
      ],
      "functional_data": {
        "summary": "Functional capacity declined markedly over time.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The majority of patients with ATTRv had more severe disease at baseline.",
      "key_quotes": [
        "Patients with ATTRv, compared with ATTRwt, had more severe disease at baseline.",
        "Overall, all-cause mortality was greatest in patients with ATTRv who were NYHA Class III at baseline (78.9%)."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "All-cause, and CV-related, mortality in all patients and by genotype and NYHA class at baseline",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data focused on the TTR gene and its variants."
  }
}